Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd has announced a daily update to their ongoing share buy-back program, with 125,000 ordinary fully paid securities purchased on the previous day, bringing the total to 455,864 shares bought back. This move reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.